Corvus Pharmaceuticals Inc (CRVS) — Long-term Investment Intensity
Corvus Pharmaceuticals Inc (CRVS) has a Long-term Investment Intensity of 15.5% as of December 2025. Long-term investments of $10.99 Million represent 15.5% of total assets of $71.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CRVS book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Corvus Pharmaceuticals Inc Long-term Investment Intensity (2020–2025)
This chart shows how Corvus Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the intensity stands at 15.5%, reflecting long-term investments of $10.99 Million against total assets of $71.12 Million USD. Also explore CRVS current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Corvus Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Corvus Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Corvus Pharmaceuticals Inc (CRVS) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 15.5% | $10.99 Million | $71.12 Million | ▼ -2.7 pp |
| 2024 | 18.2% | $12.54 Million | $68.91 Million | ▼ -17.2 pp |
| 2023 | 35.4% | $16.12 Million | $45.55 Million | ▲ +3.3 pp |
| 2022 | 32.1% | $21.88 Million | $68.24 Million | ▲ +0.8 pp |
| 2021 | 31.3% | $34.27 Million | $109.45 Million | ▼ -12.2 pp |
| 2020 | 43.5% | $37.23 Million | $85.53 Million | — |